Literature DB >> 29665354

PRMT1 negatively regulates activation-induced cell death in macrophages by arginine methylation of GAPDH.

Jun-Ho Cho1, Rana Lee1, Eunju Kim1, Yea Eun Choi1, Eui-Ju Choi2.   

Abstract

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is implicated in cell death in addition to a role as a glycolytic enzyme. In particular, when cells are exposed to cellular stressors involving nitric oxide (NO) production, GAPDH can undergo NO-induced S-nitrosylation and S-nitrosylated GAPDH has been shown to elicit apoptosis. However, the mechanism underlying the regulation of the pro-apoptotic function of GAPDH remains unclear. Here, we found that protein arginine methyltransferase 1 (PRMT1) mediated arginine methylation of GAPDH in primary bone marrow-derived macrophages in a NO-dependent manner. Moreover, PRMT1 inhibited S-nitrosylation of GAPDH as well as its binding to SIAH1, thereby reducing the nuclear translocation of GAPDH in lipopolysaccharide (LPS)/interferon (IFN)-γ-activated macrophages. Furthermore, depletion of PRMT1 expression by RNA interference potentiated LPS/IFN-γ-induced apoptosis in macrophages. Taken together, our results suggest that PRMT1 has a previously unrecognized function to inhibit activation-induced cell death of macrophages through arginine methylation of GAPDH.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arginine methylation/GAPDH/ macrophage/nitric oxide/PRMT1

Mesh:

Substances:

Year:  2018        PMID: 29665354     DOI: 10.1016/j.yexcr.2018.04.012

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  4 in total

1.  The role of posttranslational modification in moonlighting glyceraldehyde-3-phosphate dehydrogenase structure and function.

Authors:  Michael A Sirover
Journal:  Amino Acids       Date:  2021-03-02       Impact factor: 3.520

2.  Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer.

Authors:  Ming-Chuan Hsu; Ya-Li Tsai; Chia-Hsien Lin; Mei-Ren Pan; Yan-Shen Shan; Tsung-Yen Cheng; Skye Hung-Chun Cheng; Li-Tzong Chen; Wen-Chun Hung
Journal:  J Hematol Oncol       Date:  2019-07-19       Impact factor: 17.388

3.  Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A.

Authors:  Yu Lei; Ping Han; Yu Chen; Han Wang; Shuhui Wang; Muru Wang; Jingmei Liu; Wei Yan; Dean Tian; Mei Liu
Journal:  Clin Transl Med       Date:  2022-01

4.  Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers.

Authors:  Kwang-Yu Chang; Nai-Jung Chiang; Shang-Yin Wu; Chia-Jui Yen; Shang-Hung Chen; Yu-Min Yeh; Chien-Feng Li; Xiaoxing Feng; Katherine Wu; Amanda Johnston; John S Bomalaski; Bor-Wen Wu; Jianjun Gao; Sumit K Subudhi; Ahmed O Kaseb; Jorge M Blando; Shalini S Yadav; Peter W Szlosarek; Li-Tzong Chen
Journal:  Oncoimmunology       Date:  2021-07-12       Impact factor: 8.110

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.